Prakt. lékáren. 2018; 14(3): 135-139 | DOI: 10.36290/lek.2018.027

Options of self-treatment in increased fatigue: What a pharmacist can advise

Vilma Vranová
Ústav aplikované farmacie, Farmaceutická fakulta VFU Brno

Fatigue is usually defined as a subjective feeling of weariness, lack of energy, and exhaustion. An inability to find the right amountand type of rest is the cause of many illnesses leading, for instance, to impaired defence against infections; dysfunction and diseaseof the cardiovascular system; gastrointestinal, urogenital, and autoimmune diseases; backache; as well as oncological diseases.The treatment for chronic fatigue is based on determination of objective causes of its development and their elimination. Thepresent article mainly deals with the issue of supportive treatment with registered phytopharmaceuticals.

Keywords: fatigue, Rhodiola rosea, Valeriana officinalis, Ginkgo biloba

Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vranová V. Options of self-treatment in increased fatigue: What a pharmacist can advise. Praktické lékárenství. 2018;14(3):135-139. doi: 10.36290/lek.2018.027.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bystroň J. Chronický únavový syndrom - módní onemocnění? Praktické lékárenství, 12-14.
    2. Bystroň J. Imunologická problematika chronických únavových stavů. Postgraduální medicína. https://zdravi.euro.cz/clanek/postgradualni-medicina/imunologicka-problematika-chronickych-unavovych-stavu-413559
    3. Červenková R, Kolář P. (2018). Labyrint pohybu. Praha: Vyšehrad. doi:978-80-7429-975-9
    4. WADA https://www.wada-ama.org/
    5. Greenberg JA, et al.. Coffee, diabetes, and weight control. Am J ClinNutr 2006; 84: 682-693. Go to original source... Go to PubMed...
    6. Tavares C, et al. Caffeine in the Treatment of Pain. Rev Bras Anestesiol. 2012; 62: 3: 387-401. Go to original source... Go to PubMed...
    7. Diksha P, et al. Interaction of Antipsychotics Drugs and Caffeine. Sch. Acad. J. Pharm., 2014; 3(5): 383-387.
    8. Maxová M. Může konzumace kávy ovlivnit riziko rozvoje diabetu 2. typu? Klin FarmakolFarm 2009; 23(2): 83-84.
    9. Darbynian V. Rhodiola rosea in stress induced fatigue - A double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine, Vol. 7(5)., 365-371.
    10. Spasov AA. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodio/a rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, Vol. 7(2), 85-89. Go to PubMed...
    11. Jówko E. (2016). Effects of Rhodiola rosea supplementation on mental performance, physical capacity, and oxidative stress biomarkers in healthy men. Journal of Sport and Health Science. doi:10.1016/j.jshs.2016.05.005 Go to original source... Go to PubMed...
    12. Gerbarg PL. (2016) . Pause menopause with Rhodiola rosea, a natural selective estrogen receptor modulator. Phytomedicine(23), 763-769. Go to original source...
    13. Saratikov AS. The Golden Root (Rhodiola rosea). Tomsk University Publishing, Tomsk, 126 s.
    14. Kelly GS. Rhodiola rosea: a possible plant adaptogen. Altern. Med. Rev. 6, 293-302.
    15. Brown RP, et al., Rhodiola rosea: a phytomedicinal overview. HerbalGram 56, 40-52.
    16. Saratikov AS, Krasnov EA, Rhodiola rosea (Golden root) Fourth edition, Revised and Enlarged. Tomsk State University Publishing House, 292 s.
    17. Panossian AG, Wikman G, Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity. Pharmaceuticals 3, 188-224 Go to PubMed...
    18. Panossian AG, et al. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 17, 481-493. Go to PubMed...
    19. Cuerrier A, Ampong-Nyarko K. (Eds.) Rhodiola rosea, in Series: Traditional Herbal Medicines for Modern Times. CRC Press, Boca Raton-London-New York, 304 s.
    20. Martin J, et al. Léčivé rostliny s hypnotickým a sedativním účinkem. Prakt. lékáren. 2014; 10(6): 226-228.
    21. Jirák R. Extractum ginkgo biloba EGb761 a jeho využití v psychiatrii, Neurologie pro praxi, 2018, Supplementum, ročník 19. Go to original source...
    22. Mazza M, Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. European Journal of Neurology 2006; 13: 981-985. Go to original source... Go to PubMed...
    23. Smith RAJ, Robin AJ, et al. Mitochondrial Pharmacology. Trends in Pharmacological Sciences 2002; 21(6): 341-352. Go to original source... Go to PubMed...
    24. Tan MS, et al. Efficacy and adverse effects of Ginkgo biloba for cognitive impairment and dementia: A systematic review and Meta-analysis. Journal of Alzheimer's disease. 2015; (43(2): 589-603. Go to original source... Go to PubMed...
    25. Vellas B, et al. GuidAge Study Group. Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's dinase (GuidAge): A randomised, placebo-controlled trial. Lancet Neuro. 2012; 11(10): 851-859. Go to original source... Go to PubMed...
    26. White HL, et al. Extracts of Gingko biloba leaves inhibits monoamine oxidas. Life Sci 1996; 58(16): 1315. Go to original source... Go to PubMed...
    27. Hassanzadeh M, et al. Comparing the effects of relaxation technique and inhalation aromatherapy on fatigue in patients undergoing hemodialysis. Complementary Therapies in Clinical Practice 2018; 31: 210e214. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.